ST7612AA1 - CAS 1428535-92-5

ST7612AA1 is a novel potent and oral HDCA inhibitor that acts as an HIV-1 latency reactivator. ST7612AA1 showed significant antitumor activity at low concentrations in vitro and in vivo. ST7612AA1 has potential anticancer activity and can be used to study malaria.

HIV Protease, DNA/RNA Synthesis, HDAC

Proteases/Proteasome, Cell Cycle/Checkpoint, DNA Damage/DNA Repair, Chromatin/Epigenetic, Microbiology/Virology

1428438

>99.99%

C20H27N3O4S

405.51

C(N[C@H](C(NC1=CC=CC=C1)=O)CCCCCSC(C)=O)(=O)[C@@H]2NC(=O)CC2

-20°C

Ice Packs

Small Compound